Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial
Press Release Nicox Announces Last Patient Completes Final Visit in NCX 470…
Aurion Biotech Named to Fast Companys Annual List of the Worlds Most Innovative Companies of 2025
Ophthalmology Cell Therapy Innovator Included with Other Leading Companies SEATTLE & CAMBRIDGE,…
PulseSight Therapeutics announces the initiation of the clinical plan of PST-611, Transferrin Vectorized Therapy for dry AMD/Geographic Atrophy
January 14, 2025 03:00 ET | Source: PulseSight Therapeutics S.A.S PARIS, Jan.…
Ring Therapeutics Announces New Strategic Partnerships with A*STAR and SERI to Establish Gene Therapy R&D Efforts in Singapore, a Growing Global Biotech Hub
CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life…